Procter & Gamble Health Share Price | Procter & Gamble Health Stock Screener
PGHL
Pharmaceuticals
Share Price NSE
₹6247.50
▲
595.00 (10.53%)
Share Price BSE
₹6247.30
▲
595.65 (10.54%)
As of May 27, 2026, the Procter & Gamble Health share price (NSE: PGHL) is ₹6,247.50 on NSE and ₹6,247.30 on BSE, up 10.53% from the previous close, with shares trading between ₹5,848.50 and ₹6,700.00, and a 52-week range of ₹4,778.60–₹6,581.50.
Check PGHL 52-week high low for the annual price range and momentum.
Use the Procter & Gamble Health stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Procter & Gamble Health Market Cap
₹10,370.46 Cr.
PGHL P/E Ratio (TTM)
31.96
Procter & Gamble Health P/B Ratio
15.14
EPS (TTM)
₹141.00
Dividend Yield
2.21%
Debt to Equity
0.02
PGHL 52 Week High
₹6581.50
Procter & Gamble Health 52 Week Low
₹4778.60
Operating Margin
34.00%
Profit Margin
24.76%
PGHL Revenue (TTM)
₹945.00
EBITDA
₹329.00
Net Income
₹234.00
Total Assets
₹841.00
Total Equity
₹525.00
Procter & Gamble Health Share Price Chart
Screen Procter & Gamble Health share price with an interactive chart. Analyse PGHL price trends and volatility across different timeframes.
Procter & Gamble Health Company Profile - Fundamental Screener
Screen Procter & Gamble Health company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for PGHL shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE199A01012
Procter & Gamble Health Balance Sheet Screener
Screen PGHL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 841 | 794 | 794 | 1,101 | 888 | 986 | 1,176 | 1,760 | 991 | 879 |
| Current Assets | 556 | 526 | 524 | 796 | 608 | 727 | 954 | 1,534 | 752 | 636 |
| Fixed Assets | 116 | 116 | 129 | 144 | 112 | 104 | 101 | 104 | 115 | 111 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 62 | 42 | 37 | 46 | 40 | 44 | 42 | 27 | 33 | 29 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 525 | 537 | 538 | 751 | 617 | 704 | 906 | 1,540 | 733 | 664 |
| Share Capital | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 |
| Reserves & Surplus | 508 | 520 | 522 | 734 | 600 | 687 | 890 | 1,524 | 717 | 647 |
Procter & Gamble Health Income Statement Screener - Profit & Revenue Analysis
Screen Procter & Gamble Health income statement and profit fundamentals.
Analyze PGHL quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Procter & Gamble Health share price evaluation.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 945 | 1,167 | 1,248 | 1,128 | 1,027 | 1,425 | 873 | 722 | 1,017 | 963 |
| Expenses | 616 | 845 | 905 | 847 | 763 | 1,041 | 701 | 621 | 877 | 856 |
| EBITDA | 329 | 322 | 343 | 281 | 264 | 384 | 173 | 101 | 140 | 107 |
| Operating Profit % | 34.00% | 27.00% | 26.00% | 24.00% | 24.00% | 23.00% | 17.00% | 11.00% | 12.00% | 9.00% |
| Depreciation | 17 | 27 | 28 | 27 | 30 | 30 | 21 | 19 | 25 | 23 |
| Interest | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 312 | 273 | 314 | 253 | 233 | 355 | 158 | 99 | 115 | 83 |
| Tax | 77 | 72 | 85 | 61 | 57 | 101 | 56 | 38 | 36 | 30 |
| Net Profit | 234 | 201 | 230 | 193 | 177 | 254 | 102 | 61 | 79 | 54 |
| EPS | 141.00 | 121.00 | 138.00 | 116.00 | 107.00 | 153.00 | 505.27 | 56.60 | 47.70 | 32.30 |
Procter & Gamble Health Cash Flow Screener - Liquidity Fundamentals
Screen PGHL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 169 | 228 | 236 | 170 | 247 | 235 | -130 | 54 | 107 | 84 |
| Investing Activities | 10 | -7 | -22 | -26 | -32 | 165 | 1,270 | -48 | -75 | -68 |
| Financing Activities | -235 | -418 | -99 | -289 | -387 | -883 | -30 | -22 | -15 | -12 |
| Net Cash Flow | -57 | -197 | 116 | -145 | -172 | -483 | 1,109 | -16 | 17 | 4 |
Procter & Gamble Health Shareholding Pattern Screener
See Procter & Gamble Health shareholding pattern with promoter, FII, and DII holdings.
Check Procter & Gamble Health promoter holding and ownership changes for PGHL on TickJournal.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 51.82% | 51.82% | 51.82% | 51.82% | 51.82% | 51.82% | 51.82% | 51.82% |
| FII Holding | 6.20% | 6.87% | 6.99% | 7.24% | 6.97% | 6.24% | 6.40% | 6.61% |
| DII Holding | 13.68% | 14.21% | 14.16% | 13.91% | 13.84% | 13.73% | 14.55% | 14.84% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 23.17% | 21.90% | 21.89% | 22.15% | 22.43% | 22.61% | 21.82% | 21.46% |
| Other Holding | 5.14% | 5.21% | 5.14% | 4.89% | 4.94% | 5.60% | 5.41% | 5.28% |
| Shareholder Count | 50,883 | 53,993 | 52,478 | 50,006 | 49,302 | 56,778 | 55,923 | 54,792 |
Procter & Gamble Health Share Dividend Screener - Share Yield Analysis
Check Procter & Gamble Health dividend history with payout and yield data.
View Procter & Gamble Health dividend details including ex-dates and amounts for PGHL stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹125.00 | 2.60% |
| 2024-March | ₹260.00 | 5.05% |
| 2023-March | ₹95.00 | 2.02% |
| 2022-March | ₹52.50 | 1.12% |
| 2021-March | ₹130.00 | 3.25% |
| 2020-March | ₹230.00 | 3.71% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹440.00 | 11.91% |
| 2017-March | ₹15.00 | 1.00% |
Procter & Gamble Health Stock Index Membership
See which indices include Procter & Gamble Health stock.
Check PGHL index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE INDEX BSE HC
BSE INDEX BSE500
BSE INDEX MSL400
BSE INDEX SML250
BSE INDEX SMLCAP
Procter & Gamble Health Market Events Screener - Corporate Actions
Get Procter & Gamble Health corporate actions including splits, bonuses, and buybacks.
Check Procter & Gamble Health stock events that may affect PGHL share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-05-26 | 2026-05-26 | Quarterly Result Announcement | NA | 15.83% |
| 2026-02-12 | 2026-02-12 | Dividend | ₹ 50.00 /share | 4.56% |
| 2026-02-12 | 2026-02-12 | Dividend | ₹ 110.00 /share | 4.56% |
| 2026-02-06 | 2026-02-06 | Quarterly Result Announcement | NA | -6.98% |
| 2025-11-05 | 2025-11-05 | Quarterly Result Announcement | NA | -3.34% |
| 2025-08-29 | 2025-08-29 | Annual General Meeting | NA | 1.83% |
| 2025-08-22 | 2025-08-22 | Dividend | ₹ 45.00 /share | 10.63% |
| 2025-08-01 | 2025-08-01 | Quarterly Result Announcement | NA | 0.33% |
| 2025-05-29 | 2025-05-29 | Quarterly Result Announcement | NA | 5.91% |
| 2025-02-21 | 2025-02-21 | Dividend | ₹ 80.00 /share | 1.63% |
| 2025-02-12 | 2025-02-12 | Quarterly Result Announcement | NA | -3.43% |
| 2024-12-05 | 2024-12-05 | Annual General Meeting | NA | -0.50% |
| 2024-11-28 | 2024-11-29 | Dividend | ₹ 60.00 /share | -4.69% |
| 2024-11-04 | 2024-11-04 | Quarterly Result Announcement | NA | -1.04% |
| 2024-02-14 | 2024-02-14 | Dividend | ₹ 150.00 /share | 7.15% |
Procter & Gamble Health Competitors Screener - Peer Comparison
Screen PGHL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 442,509 | 38.37 | 58,220 | 6.38% | 11,565 | 54.66 |
| Divis Laboratories | 180,452 | 69.82 | 10,560 | 8.73% | 2,520 | 59.28 |
| Torrent Pharmaceuticals | 153,580 | 70.46 | 13,753 | 19.18% | 2,028 | 60.91 |
| Cipla | 114,559 | 29.64 | 27,712 | -2.46% | 3,783 | 64.86 |
| Dr Reddys Laboratories | 110,089 | 26.69 | 33,593 | -0.44% | 3,998 | 54.22 |
| Zydus Life Science | 109,257 | 21.19 | 26,720 | 13.65% | 5,242 | 75.42 |
| Lupin | 104,041 | 19.33 | 27,488 | 19.98% | 5,345 | 46.91 |
| Mankind Pharma | 99,915 | 51.52 | 14,278 | 12.03% | 1,750 | 55.29 |
| Aurobindo Pharma | 83,397 | 24.27 | 33,385 | 3.21% | 3,376 | 47.24 |
| Laurus Labs | 74,592 | 83.31 | 6,813 | 21.03% | 884 | 80.70 |
Procter & Gamble Health Company Announcements - News Screener
Screen PGHL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| Compliances-Reg.24(A)-Annual Secretarial Compliance | - | |
| 2026-05-28 | Record Date For Purpose Of Dividend | - |
| 2026-05-28 | Corporate Action-Board approves Dividend | - |
| 2026-05-28 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-05-28 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-05-28 | Outcome Of The Board Meeting Held On May 26 2026 | - |
| 2026-05-28 | Board Meeting Outcome for Outcome Of The Board Meeting Held On May 26 2026 | - |
| 2026-04-30 | Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Sale Of Immovable Properties | - |
| 2026-04-06 | Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A | - |
| 2026-04-06 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-03-27 | Board Meeting Intimation for Intimation Of Board Meeting | - |
| 2026-03-27 | Closure of Trading Window | - |
| 2026-02-06 | Communication In Respect Of Deduction Of Tax At Source (TDS) On The Amount Of Dividend Income From Procter & Gamble Health Limited | - |
| 2026-02-06 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-02-06 | Record Date | - |
| 2026-02-06 | Unaudited Financial Results For The Quarter Ended December 31 2025 | - |
| 2026-02-06 | Corporate Action-Board approves Dividend | - |
| 2026-02-06 | Board Meeting Outcome for Outcome Of Board Meeting Held On February 6 2026 | - |
| 2026-01-21 | Update on board meeting | - |
| 2026-01-16 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |